Literature DB >> 15643424

Surface charge and hydrophobicity determine ErbB2 binding to the Hsp90 chaperone complex.

Wanping Xu1, Xitong Yuan, Zhexin Xiang, Edward Mimnaugh, Monica Marcu, Len Neckers.   

Abstract

The molecular chaperone Hsp90 modulates the function of specific cell signaling proteins. Although targeting Hsp90 with the antibiotic inhibitor geldanamycin (GA) may be a promising approach for cancer treatment, little is known about the determinants of Hsp90 interaction with its client proteins. Here we identify a loop within the N lobe of the kinase domain of ErbB2 that determines Hsp90 binding. The amino acid sequence of the loop determines the electrostatic and hydrophobic character of the protein's surface, which in turn govern interaction with Hsp90. A point mutation within the loop that alters ErbB2 surface properties disrupts Hsp90 association and confers GA resistance. Notably, the immature ErbB2 point mutant remains sensitive to GA, suggesting that mature and nascent client kinases may use distinct motifs to interact with the Hsp90 chaperone complex.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15643424     DOI: 10.1038/nsmb885

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  72 in total

1.  Hsp70:CHIP Ubiquitinates Dysfunctional but Not Native Neuronal NO Synthase.

Authors:  Amanda K Davis; Natalie F McMyn; Miranda Lau; Yoshihiro Morishima; Yoichi Osawa
Journal:  Mol Pharmacol       Date:  2020-06-26       Impact factor: 4.436

Review 2.  HSP90 at the hub of protein homeostasis: emerging mechanistic insights.

Authors:  Mikko Taipale; Daniel F Jarosz; Susan Lindquist
Journal:  Nat Rev Mol Cell Biol       Date:  2010-06-09       Impact factor: 94.444

3.  Molecular dynamics analysis of conserved hydrophobic and hydrophilic bond-interaction networks in ErbB family kinases.

Authors:  Andrew J Shih; Shannon E Telesco; Sung-Hee Choi; Mark A Lemmon; Ravi Radhakrishnan
Journal:  Biochem J       Date:  2011-06-01       Impact factor: 3.857

4.  Structure of an Hsp90-Cdc37-Cdk4 complex.

Authors:  Cara K Vaughan; Ulrich Gohlke; Frank Sobott; Valerie M Good; Maruf M U Ali; Chrisostomos Prodromou; Carol V Robinson; Helen R Saibil; Laurence H Pearl
Journal:  Mol Cell       Date:  2006-09-01       Impact factor: 17.970

5.  Hsp90 inhibition transiently activates Src kinase and promotes Src-dependent Akt and Erk activation.

Authors:  Fumitaka Koga; Wanping Xu; Tatiana S Karpova; James G McNally; Roland Baron; Len Neckers
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-14       Impact factor: 11.205

6.  Loss of Hsp90 association up-regulates Src-dependent ErbB2 activity.

Authors:  Wanping Xu; Xitong Yuan; Kristin Beebe; Zhexin Xiang; Len Neckers
Journal:  Mol Cell Biol       Date:  2006-10-09       Impact factor: 4.272

Review 7.  Nexus of signaling and endocytosis in oncogenesis driven by non-small cell lung cancer-associated epidermal growth factor receptor mutants.

Authors:  Byung Min Chung; Eric Tom; Neha Zutshi; Timothy Alan Bielecki; Vimla Band; Hamid Band
Journal:  World J Clin Oncol       Date:  2014-12-10

8.  Geldanamycin selectively targets the nascent form of ERBB3 for degradation.

Authors:  Candice S Gerbin; Ralf Landgraf
Journal:  Cell Stress Chaperones       Date:  2010-01-19       Impact factor: 3.667

9.  Hsp90 regulates the phosphorylation and activity of serum- and glucocorticoid-regulated kinase-1.

Authors:  Larissa Belova; Deanna R Brickley; Betty Ky; Sanjay K Sharma; Suzanne D Conzen
Journal:  J Biol Chem       Date:  2008-05-02       Impact factor: 5.157

10.  Canonical and kinase activity-independent mechanisms for extracellular signal-regulated kinase 5 (ERK5) nuclear translocation require dissociation of Hsp90 from the ERK5-Cdc37 complex.

Authors:  Tatiana Erazo; Ana Moreno; Gerard Ruiz-Babot; Arantza Rodríguez-Asiain; Nicholas A Morrice; Josep Espadamala; Jose R Bayascas; Nestor Gómez; Jose M Lizcano
Journal:  Mol Cell Biol       Date:  2013-02-19       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.